Epidemiology of nonsyndromic conotruncal heart defects in Texas, 1999-2004

Jin Long1, Tunu Ramadhani, Laura E Mitchell

  • 1Institute of Biosciences and Technology, Texas A&M University System Health Science Center, Houston, TX 77382, USA.

Insights

This study investigated risk factors for three conotruncal heart defects (CTDs). Advancing maternal age increased risk for all three, with other factors varying by specific CTD.

Area of Science:

  • Epidemiology
  • Pediatric Cardiology
  • Birth Defects Research

Background:

  • Congenital heart defects (CHDs) are common but poorly understood.
  • Conotruncal heart defects (CTDs) are a subgroup of CHDs.
  • Etiologic heterogeneity may exist even within CTD subgroups.

Purpose of the Study:

  • To identify and compare maternal and infant characteristics associated with three specific CTDs: truncus arteriosus (TA), dextro-transposition of the great arteries (d-TGA), and tetralogy of Fallot (TOF).

Main Methods:

  • Utilized data from the Texas Birth Defects Registry (1999-2004) for nonsyndromic cases.
  • Employed Poisson regression to estimate prevalence ratios for each condition.
  • Used polytomous logistic regression to compare associations between d-TGA and TOF.

Main Results:

  • Prevalence rates per 10,000 live births: TA (0.35), d-TGA (1.98), TOF (2.40).
  • Advancing maternal age significantly increased risk for all three CTDs.
  • Specific associations found: TA with Texas-Mexico border residence; d-TGA with infant sex, maternal race/ethnicity, prior birth history, birth year; TOF with maternal race/ethnicity and education.
  • Significant differences in variable associations were noted between d-TGA and TOF.

Conclusions:

  • Findings contribute to the limited understanding of CTD epidemiology.
  • Highlights distinct risk factor profiles for different CTDs.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...